Atlantic Edge Private Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Atlantic Edge Private Wealth Management, LLC holds 32 biotech & pharma companies tracked by BioSniper, totaling $13.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
32
Total value held
$13.2M
| Company | Shares | Value |
|---|---|---|
| MCKMcKesson Corporation | 5,157 | $4.5M |
| MRKMerck & Co., Inc. | 17,600 | $2.1M |
| INCYIncyte Corp. | 14,160 | $1.3M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,474 | $1.1M |
| LLYELI LILLY & Co | 1,210 | $1.1M |
| JNJJOHNSON & JOHNSON | 2,879 | $704K |
| ABBVAbbVie Inc. | 2,416 | $526K |
| PMPhilip Morris International Inc | 2,439 | $403K |
| AMGNAMGEN INC | 982 | $346K |
| NVSNovartis AG | 2,230 | $341K |
| ABTABBOTT LABORATORIES | 3,042 | $312K |
| BMYBRISTOL MYERS SQUIBB CO | 1,692 | $103K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 125 | $56K |
| GMOptec International, Inc. | 650 | $48K |
| AZNASTRAZENECA PLC | 207 | $41K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 139 | $38K |
| CORCencora Inc. | 85 | $27K |
| ZTSZoetis Inc. | 179 | $21K |
| CAHCardinal Health Inc. | 100 | $21K |
| PFEPFIZER INC | 692 | $19K |
| GILDGILEAD SCIENCES, INC. | 75 | $10K |
| NVONovo Nordisk A/S | 275 | $10K |
| SNYSanofi | 149 | $7K |
| ESPREsperion Therapeutics, Inc. | 1,600 | $4K |
| AVNSAvanos Medical Inc. | 299 | $4K |
| DFTXDefinium Therapeutics Inc. | 193 | $4K |
| GEHCGE HealthCare Technologies Inc. | 30 | $2K |
| RGENREPLIGEN CORP | 15 | $2K |
| PCVXVaxcyte, Inc. | 25 | $1K |
| VTRSViatris Inc | 69 | $933 |
| HELPCYBIN INC. | 137 | $658 |
| CGCCanopy Growth Corp | 25 | $24 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.